Wilfried Mutombo Kalonji, after graduating from medical school in 2004, dedicated his life to helping the residents of Kasansa, DRC, as their sole physician.
Mutombo's experience with melarsoprol posed a grave challenge; the drug is toxic and has a distressing death rate of 5-10%, impacting both patients and their families.
Collaborating with the Drugs for Neglected Diseases Initiative, Mutombo works on developing safer treatments for sleeping sickness, which has seen a dramatic reduction in cases.
Acoziborole, a promising single-dose medication, has the potential to treat both confirmed cases and interrupt the transmission of sleeping sickness, altering the disease's trajectory.
Collection
[
|
...
]